(Q52209033)

27 April 2018

title

Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6150331

15 August 2023

1 reference

paralytic poliomyelitis

1 reference

3

J Salk

1 reference

27 April 2018

Darrell Salk

1

object named as

D Salk

1 reference

27 April 2018

author name string

A. L. van Wezel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6150331

15 August 2023

language of work or name

English

0 references

publication date

1 December 1984

1 reference

27 April 2018

8 December 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6150331

full work available at URL

15 August 2023

https://api.elsevier.com/content/article/PII:S0140673684908304?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

https://api.elsevier.com/content/article/PII:S0140673684908304?httpAccept=text/plain

15 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

15 August 2023

1 reference

27 April 2018

volume

2

1 reference

27 April 2018

issue

8415

1 reference

27 April 2018

page(s)

1317-1321

1 reference

27 April 2018

Persistence of immunity after administration of formalin-treated poliovirus vaccine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Control of Influenza and Poliomyelitis with Killed Virus Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Vaccination Against Paralytic Poliomyelitis Performance and Prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Poliomyelitis: severity and type of disease in different age groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

A concept of the mechanism of immunity for preventing paralysis in poliomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Tissue culture techniques and their application to original isolation, growth, and assay of poliomyelitis and orphan viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

The measurement of the D-antigen in poliovirus preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Antigenic and Structural Relatedness among Non-capsid and Capsid Polypeptides of Polioviruses belonging to Different Serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Evidence for common, intertypic antigenic determinants on poliovirus capsid polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Immunochemical Studies of Polioviruses: Identification of Immunoreactive Virus Capsid Polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Consequences of the introduction of the new inactivated poliovirus vaccine into the Expanded Programme on Immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Immunity Induced by Inactivated Poliovirus Vaccine and Excretion of Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2990830-4

7 January 2021

Killed poliovirus antigen titration in humans

5

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

A controlled trial with inactivated poliovaccine

15 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

Sero-immunity to poliomyelitis virus in Sweden 10 years after introduction of vaccinations with inactivated poliovirus vaccine. A pilot study

15 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

Antibody stimulation in individuals without demonstrable poliovirus antibodies following a fifth injection of inactivated poliovirus vaccine

15 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

Requirements for persistent immunity to poliomyelitis

15 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

Antigenicity and immunogenicity of poliovirus capsid proteins

15 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

Epidemiological events surrounding a paralytic case of poliomyelitis in Sweden

15 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(84)90830-4

15 August 2023

Identifiers

1 reference

27 April 2018

1 reference

27 April 2018